Telomir Pharmaceuticals, Inc. · NASDAQ:TELO
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 5.50% stake in Telomir Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 9, 2025 · Filed Sep 18, 2025
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 5.50% stake in Telomir Pharmaceuticals, Inc., 1,774,900 shares, as a passive investor on Sep 9, 2025. Filed Sep 18, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 1,774,900
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 5.50% | 1,774,900 |
Source
Related
- Telomir Pharmaceuticals, Inc.
- John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
- Telomir Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Aug 14, 2026
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Feb 12, 2026
- Form 4 · Aminov Erez · Apr 24, 2026